Regulatory insights into nanomedicine and gene vaccine innovation : Safety assessment, challenges, and regulatory perspectives

Thumbnail Image
1-s2.0-S1742706124001831-main.pdf (1.54 MB)
Identifiers
URI: https://hdl.handle.net/10641/7020
ISSN: 1742-7061
DOI: 10.1016/j.actbio.2024.04.010

Publication date

2024-05

Start date of the public exhibition period

End date of the public exhibition period

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Share
Export

Research Projects

Organizational Units

Journal Issue

Doctoral program

Description

Publisher Copyright: © 2024 The Author(s)

Keywords

Ethical considerations, Gene vaccines, Intellectual property rights, Nanomedicines, Regulatory issues, Safety assessment, Biotechnology, Biochemistry, Biomaterials, Biomedical Engineering, Molecular Biology, SDG 3 - Good Health and Well-being, Journal Article, Research Support, Non-U.S. Gov't, Review, Yes, yes

Citation

Souto, E B, Blanco-Llamero, C, Krambeck, K, Kiran, N S, Yashaswini, C, Postwala, H, Severino, P, Priefer, R, Prajapati, B G & Maheshwari, R 2024, 'Regulatory insights into nanomedicine and gene vaccine innovation : Safety assessment, challenges, and regulatory perspectives', Acta Biomaterialia, vol. 180, pp. 1-17. https://doi.org/10.1016/j.actbio.2024.04.010

Collections

FACULTAD DE CIENCIAS DE LA SALUD